TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth

Hippo and TGF-β converge on CTGF to promote malignant mesothelioma.

• Publication year

  2012

• Venue

  Journal of Experimental Medicine

• Publication date

  2012-03-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1084/jem.20111653PMID 22329991PMCID 3302232
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Malignant Pleural Mesothelioma

  2017cited by this paper
• Malignant pleural mesothelioma.

  2012cited by this paper
• LATS2 is a tumor suppressor gene of malignant mesothelioma.

  2011cited by this paper
• The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals.

  2010cited by this paper
• Connective Tissue Growth Factor Knockdown Attenuated Matrix Protein Production and Vascular Endothelial Growth Factor Expression Induced by Transforming Growth Factor‐β1 in Cultured Human Peritoneal Mesothelial Cells

  2010cited by this paper
• Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells

  2010cited by this paper
• The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-β-SMAD pathway.

  2010cited by this paper
• YAP, TAZ, and Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease.

  2009cited by this paper
• Hypoxia and TGF-β Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone Microenvironment

  2009cited by this paper
• Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways.

  2009cited by this paper
• Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein.

  2009cited by this paper
• Malignant pleural mesothelioma.

  2009cited by this paper
• The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth.

  2009cited by this paper
• Matrix crosslinking forces tumor progression by enhancing integrin signaling.

  2009cited by this paper
• YAP1 is involved in mesothelioma development and negatively regulated by Merlin through phosphorylation.

  2008cited by this paper
• TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal

  2008cited by this paper
• TEAD mediates YAP-dependent gene induction and growth control.

  2008influential reference
• Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32

  2008cited by this paper
• TGFbeta in Cancer.

  2008cited by this paper
• A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection.

  2007cited by this paper
• Stromal induction of breast cancer: Inflammation and invasion

  2007cited by this paper
• Genomic profiling of malignant pleural mesothelioma with array‐based comparative genomic hybridization shows frequent non‐random chromosomal alteration regions including JUN amplification on 1p32

  2007cited by this paper
• Prognostic Factors in the Treatment of Malignant Pleural Mesothelioma at a Large Tertiary Referral Center

  2007influential reference
• Elucidation of a universal size-control mechanism in Drosophila and mammals.

  2007cited by this paper
• A Novel Small-Molecule Inhibitor of Transforming Growth Factor β Type I Receptor Kinase (SM16) Inhibits Murine Mesothelioma Tumor Growth In vivo and Prevents Tumor Recurrence after Surgical Resection

  2007cited by this paper
• The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis

  2006cited by this paper
• A Critical Look at Growth Factors and Epithelial-to-Mesenchymal Transition in the Adult Kidney

  2006cited by this paper
• SNIP1 is a candidate modifier of the transcriptional activity of c-Myc on E box-dependent target genes.

  2006cited by this paper
• Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis.

  2006influential reference
• Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model.

  2006cited by this paper
• Advances in malignant mesothelioma.

  2005cited by this paper
• Smad transcription factors.

  2005cited by this paper
• Soluble Type II Transforming Growth Factor-β Receptor Inhibits Established Murine Malignant Mesothelioma Tumor Growth by Augmenting Host Antitumor Immunity

  2004cited by this paper
• SD-208, a Novel Transforming Growth Factor β Receptor I Kinase Inhibitor, Inhibits Growth and Invasiveness and Enhances Immunogenicity of Murine and Human Glioma Cells In vitro and In vivo

  2004cited by this paper
• hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts.

  2003cited by this paper
• Coupling cell growth, proliferation, and death. Hippo weighs in.

  2003cited by this paper
• Hippo and its mission for growth control

  2003cited by this paper
• Hierarchical model of gene regulation by transforming growth factor β

  2003cited by this paper
• The two faces of transforming growth factor β in carcinogenesis

  2003cited by this paper
• The two faces of transforming growth factor beta in carcinogenesis.

  2003cited by this paper
• TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm.

  2001cited by this paper
• CTGF and SMADs, Maintenance of Scleroderma Phenotype Is Independent of SMAD Signaling*

  2001cited by this paper
• Role of p300, a transcriptional coactivator, in signalling of TGF‐β

  1998cited by this paper
• High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas.

  1995influential reference
• Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer.

  1995cited by this paper
• Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma.

  1989cited by this paper
• Stimulation of DNA synthesis in cultured primary human mesothelial cells by specific growth factors

  1988cited by this paper
• Comparison of production of transforming growth factor-beta and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines.

  1987cited by this paper
• Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors.

  1983cited by this paper
• Transforming growth factor production by chemically transformed cells.

  1981cited by this paper
• Growth factors from murine sarcoma virus-transformed cells.

  1978cited by this paper

• Recent advances on Hippo-YAP pathway in skin diseases

  2026cites this paper
• Interaction between ENPP1 and homologous recombination deficiency defines distinct pan-cancer signatures: A retrospective observational study

  2026cites this paper
• Blockade of YAP Mechanoactivation Prevents Neointima Formation and Adverse Remodeling in Arterialized Vein Grafts

  2025cites this paper
• Pharmacogenomic Characterization of a Large Cohort of Patient-Derived Cell Lines Identifies Therapeutic Strategies for Pleural Mesothelioma.

  2025cites this paper
• A dominant role of TGFβ in regulating T-cell size and physiology

  2025cites this paper
• Hippo/YAP signaling’s multifaceted crosstalk in cancer

  2025cites this paper
• CD47-mediated regulation of glucose and lipid metabolism: implications for the pathogenesis of MASLD

  2025cites this paper
• Podocyte YAP and TAZ hyperactivation drives glomerular epithelial proliferative diseases in mice and humans.

  2025cites this paper
• CTGF (CCN2): a multifaceted mediator in breast cancer progression and therapeutic targeting

  2025cites this paper
• Silencing KMT2A with siRNA induces apoptosis and cell cycle arrest in high-grade serous ovarian carcinoma cells by modulating GOF p53-dependent pathways, highlighting its potential as a therapeutic target

  2025cites this paper
• Integrative modeling and analysis of signaling crosstalk reveal molecular switches coordinating Yes-associated protein transcriptional activities

  2024cites this paper
• Reversible and monitorable nephrotoxicity in rats by the novel potent transcriptional enhanced associate domain (TEAD) inhibitor, K-975.

  2024cites this paper
• Analysis of the DNA‐binding properties of TGF‐β‐activated Smad complexes unveils a possible molecular basis for cellular context‐dependent signaling

  2024cites this paper
• Verteporfin inhibits TGF-β signaling by disrupting the Smad2/3–Smad4 interaction

  2024cites this paper
• Activation of platelet-derived growth factor receptors regulate connective tissue growth factor protein levels via the AKT pathway in malignant mesothelioma cells.

  2024cites this paper
• Prognostic Value of TGF-β Expression in Bladder Cancer: A Systematic Review and Meta-analysis

  2024cites this paper
• TEAD transcription factor family emerges as a promising therapeutic target for oral squamous cell carcinoma

  2024cites this paper
• O-GlcNAcylation controls pro-fibrotic transcriptional regulatory signaling in myofibroblasts

  2024cites this paper
• Upregulation of CYR61 by TGF-β and YAP signaling exerts a counter-suppression of hepatocellular carcinoma

  2024cites this paper
• Bile acid receptor agonist reverses TGF-β1-mediated fibrogenesis in human induced pluripotent stem cells (iPSC)-derived kidney organoids.

  2024cites this paper
• YAP1 expression in colorectal cancer confers the aggressive phenotypes via its target genes

  2024cites this paper
• A gene signature linked to fibroblast differentiation for prognostic prediction of mesothelioma

  2024cites this paper
• Tankyrase inhibitor IWR-1 modulates HIPPO and Transforming Growth Factor β signaling in primed bovine embryonic stem cells cultured on mouse embryonic fibroblasts.

  2024cites this paper
• The Role of Hippo/YAP Pathway in the Crosstalk of Tumor Cell Signaling Pathways

  2023cites this paper
• Melodic maestros: Unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of malignant pleural mesothelioma.

  2023cites this paper
• FOXM1 Promotes Mesothelioma Cell Migration and Invasion via Activation of SMAD Signaling

  2023cites this paper
• Cullin 4B Ubiquitin Ligase Is Important for Cell Survival and Regulates TGF-β1 Expression in Pleural Mesothelioma

  2023influential citation
• NF2 alteration in mesothelioma

  2023influential citation
• TGF‐β/Smads signaling pathway, Hippo‐YAP/TAZ signaling pathway, and VEGF: Their mechanisms and roles in vascular remodeling related diseases

  2023cites this paper
• Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy

  2023cites this paper
• Tea domain transcription factor TEAD4 mitigates TGF-β signaling and hepatocellular carcinoma progression independently of YAP

  2023cites this paper
• Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma

  2023cites this paper
• Genetic dependencies associated with transcription factor activities in human cancer cell lines

  2023cites this paper
• Prolyl isomerase Pin1 promotes extracellular matrix production in hepatic stellate cells through regulating formation of the Smad3-TAZ complex.

  2023cites this paper
• The TGFβ→TAK1→LATS→YAP1 Pathway Regulates the Spatiotemporal Dynamics of YAP1

  2023cites this paper
• TEAD4 as an Oncogene and a Mitochondrial Modulator

  2022cites this paper
• Challenges and limitation of MTAP immunohistochemistry in diagnosing desmoplastic mesothelioma/sarcomatoid pleural mesothelioma with desmoplastic features.

  2022cites this paper
• Targeted Drug/Gene/Photodynamic Therapy via a Stimuli‐Responsive Dendritic‐Polymer‐Based Nanococktail for Treatment of EGFR‐TKI‐Resistant Non‐Small‐Cell Lung Cancer

  2022cites this paper
• Self-Sustained Regulation or Self-Perpetuating Dysregulation: ROS-dependent HIF-YAP-Notch Signaling as a Double-Edged Sword on Stem Cell Physiology and Tumorigenesis

  2022influential citation
• Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transitions via YAP/TAZ-Hedgehog signalling axis in pancreatic cancer

  2022cites this paper
• Hybrid molecule between platanic acid and LCL-161 as a yes-associated protein (YAP) degrader.

  2022cites this paper
• Mechanical control of nuclear import by Importin-7 is regulated by its dominant cargo YAP

  2022cites this paper
• Systems modelling of TGF-β/Hippo signalling crosstalk uncovers molecular switches that coordinate YAP transcriptional complexes (submitted to iScience)

  2022cites this paper
• Pan-cancer analysis, cell and animal experiments revealing TEAD4 as a tumor promoter in ccRCC.

  2022cites this paper
• Progress with YAP/TAZ-TEAD inhibitors: a patent review (2018-present)

  2022cites this paper
• Biodegradable hydrogels with photodynamic antibacterial activity promote wound healing and mitigate scar formation.

  2022cites this paper
• Relationship between Yes-Associated Protein 1 and Prognosis of Digestive System Neoplasm: Quantitative Analysis and Bioinformatics Analysis Based on 4023 Patients

  2022cites this paper
• BMP and activin membrane-bound inhibitor regulate connective tissue growth factor controlling mesothelioma cell proliferation

  2022influential citation
• Extracellular ATP promotes angiogenesis and adhesion of TNBC cells to endothelial cells via upregulation of CTGF

  2022cites this paper
• Comparative proteomics reveals elevated CCN2 in NGLY1-deficient cells.

  2022cites this paper
• Inhibin βA is an independent prognostic factor that promotes invasion via Hippo signaling in non-small cell lung cancer

  2021influential citation
• Epithelial Cell Transforming 2 (ECT2) is regulated by Yes-associated protein 1 (YAP1) and mediates pancreatic cancer progression and metastasis.

  2021cites this paper
• The Immune System of Mesothelioma Patients: A Window of Opportunity for Novel Immunotherapies

  2021cites this paper
• Atractylenolide-I Sensitizes Triple-Negative Breast Cancer Cells to Paclitaxel by Blocking CTGF Expression and Fibroblast Activation

  2021cites this paper
• YAP in pancreatic cancer: oncogenic role and therapeutic strategy

  2021cites this paper
• A dual role of YAP in driving TGFβ-mediated endothelial-to-mesenchymal transition

  2021cites this paper
• Tumor Immune Microenvironment and Genetic Alterations in Mesothelioma

  2021cites this paper
• An Updated Understanding of the Role of YAP in Driving Oncogenic Responses

  2021cites this paper
• Narciclasine is a novel YAP inhibitor that disturbs interaction between YAP and TEAD4.

  2021cites this paper
• Frequent NF2 Inactivation in Mesothelioma: How Can We Treat Mesothelioma with Targeted Therapies for Molecular Aberrations?

  2021cites this paper
• Concurrent YAP/TAZ and SMAD signaling mediate vocal fold fibrosis

  2021cites this paper
• Pathological Characterization of Tumor Immune Microenvironment (TIME) in Malignant Pleural Mesothelioma

  2021cites this paper
• The Epithelial-to-Mesenchymal Transition (EMT) in the Development and Metastasis of Malignant Pleural Mesothelioma

  2021cites this paper
• Mesothelioma Malignancy and the Microenvironment: Molecular Mechanisms

  2021influential citation
• Comprehensive Analysis of the Expression of TGF-β Signaling Regulators and Prognosis in Human Esophageal Cancer

  2021cites this paper
• Asbestos‐induced mesothelial injury and carcinogenesis: Involvement of iron and reactive oxygen species

  2021cites this paper
• A review: hippo signaling pathway promotes tumor invasion and metastasis by regulating target gene expression

  2021cites this paper
• TAZ/TEAD complex regulates TGF-β1-mediated fibrosis in iPSC-derived renal organoids

  2021cites this paper
• CRISPR screens identify tumor‐promoting genes conferring melanoma cell plasticity and resistance

  2021cites this paper
• Digital Gene Expression Analysis of Epithelioid and Sarcomatoid Mesothelioma Reveals Differences in Immunogenicity

  2021cites this paper
• Biological Significance of YAP/TAZ in Pancreatic Ductal Adenocarcinoma

  2021cites this paper
• Three newly established immortalized mesothelial cell lines exhibit morphological phenotypes corresponding to malignant mesothelioma epithelioid, intermediate, and sarcomatoid types, respectively

  2021cites this paper
• Positive Association of Matrix Proteins Alteration with TAZ and The Progression of High-Grade Bladder Cancer

  2021cites this paper
• Histological sequence of the development of rat mesothelioma by MWCNT, with the involvement of apolipoproteins

  2021cites this paper
• LncRNA MIR497HG suppresses bladder cancer progression through disrupting the crosstalk between Hippo/Yap and TGF-β/Smad signaling

  2020cites this paper
• The novel potent TEAD inhibitor, K-975, inhibits YAP1/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma.

  2020cites this paper
• A Driver Never Works Alone—Interplay Networks of Mutant p53, MYC, RAS, and Other Universal Oncogenic Drivers in Human Cancer

  2020cites this paper
• Heterotypic 3D pancreatic cancer model with tunable proportion of fibrotic elements.

  2020cites this paper
• Silencing of lncRNA MIR497HG via CRISPR/Cas13d Induces Bladder Cancer Progression Through Promoting the Crosstalk Between Hippo/Yap and TGF-β/Smad Signaling

  2020cites this paper
• Crosstalk between YAP and TGFβ regulates SERPINE1 expression in mesenchymal lung cancer cells.

  2020cites this paper
• Targeting CTGF in Cancer: An Emerging Therapeutic Opportunity.

  2020cites this paper
• Gain-of-function CRISPR screens identify tumor-promoting genes conferring melanoma cell plasticity and therapy-resistance

  2020cites this paper
• YAP and TAZ Are Not Identical Twins.

  2020cites this paper
• LINC00968 can inhibit the progression of lung adenocarcinoma through the miR-21-5p/SMAD7 signal axis

  2020cites this paper
• Connective tissue growth factor produced by cancer-associated fibroblasts correlates with poor prognosis in epithelioid malignant pleural mesothelioma

  2020cites this paper
• Caveolin1 and YAP drive mechanically induced mesothelial to mesenchymal transition and fibrosis

  2020cites this paper
• Hepatocyte nuclear factor 4α negatively regulates connective tissue growth factor during liver regeneration

  2020cites this paper
• The Hippo Pathway in Cardiac Regeneration and Homeostasis: New Perspectives for Cell-Free Therapy in the Injured Heart

  2020cites this paper
• Role of the Hippo signaling pathway in safflower yellow pigment treatment of paraquat-induced pulmonary fibrosis

  2020cites this paper
• TAZ promotes the proliferation and osteogenic differentiation of human periodontal ligament stem cells via the p‐SMAD3

  2020cites this paper
• It Takes Two to Tango: Endothelial TGFβ/BMP Signaling Crosstalk with Mechanobiology

  2020cites this paper
• GPCR-induced YAP activation sensitizes fibroblasts to profibrotic activity of TGFβ1

  2020cites this paper
• Frequent homozygous deletion of Cdkn2a/2b in tremolite‐induced malignant mesothelioma in rats

  2020cites this paper
• Leukemia inhibitory factor promotes gastric cancer cell proliferation, migration, and invasion via the LIFR–Hippo–YAP pathway

  2020cites this paper
• Gastric Tumor Microenvironment.

  2020cites this paper
• HIF-hypoxia signaling in skeletal muscle physiology and fibrosis

  2020cites this paper
• Vitamin D3 analogue facilitates epithelial wound healing through promoting epithelial-mesenchymal transition via the Hippo pathway.

  2020cites this paper
• The Immune Microenvironment in Mesothelioma: Mechanisms of Resistance to Immunotherapy

  2019cites this paper
• Detection of TGF-β in pleural effusions for diagnosis and prognostic stratification of malignant pleural mesothelioma.

  2019cites this paper
• Regulation of TEAD Transcription Factors in Cancer Biology

  2019cites this paper